Download Free Sample Report

The global Oral Anticoagulants market was valued at US$ 14950 million in 2022 and is projected to reach US$ 23660 million by 2029, at a CAGR of 6.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
This report aims to provide a comprehensive presentation of the global market for Oral Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anticoagulants. This report contains market size and forecasts of Oral Anticoagulants in global, including the following market information:
Global Oral Anticoagulants Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Oral Anticoagulants Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Oral Anticoagulants companies in 2022 (%)

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
We has surveyed the Oral Anticoagulants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral Anticoagulants Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)

Global Oral Anticoagulants Market Segment Percentages, by Type, 2022 (%)

• Direct Thrombin Inhibitors
• Direct Factor Xa Inhibitors

Global Oral Anticoagulants Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)

Global Oral Anticoagulants Market Segment Percentages, by Application, 2022 (%)

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism
• Acute Coronary Syndrome
• Hemodialysis
• Others

Global Oral Anticoagulants Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)

Global Oral Anticoagulants Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Oral Anticoagulants revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Oral Anticoagulants revenues share in global market, 2022 (%)
• Key companies Oral Anticoagulants sales in global market, 2018-2023 (Estimated), (K Units)
• Key companies Oral Anticoagulants sales share in global market, 2022 (%)

key players include:

• Johnson & Johnson
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Sanofi
• Daiichi Sankyo
• Armatheon
• Aspen
• AstraZeneca
• Bayer
• Cellceutix
• Cosmo Pharmaceuticals
• CSL Behring
• Eisai
• GSK
• Marathon Pharmaceuticals
• Ockham Biotech
• Perosphere

Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Anticoagulants, market overview.
Chapter 2: Global Oral Anticoagulants market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Anticoagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Anticoagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Anticoagulants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.